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Original article
Chronic pain after hand-assisted laparoscopic
donor nephrectomy
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M. H. de Borst2, S. J. L. Bakker2, H. G. D. Leuvenink4 and R. A. Pol4
1Department of Radiology, 2Department of Internal Medicine, Division of Nephrology, 3Department of Anaesthesiology, and 4Department of Surgery,
Division of Transplant Surgery, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands
Correspondence to: Dr M. Zorgdrager, Department of Radiology, University Medical Centre Groningen, PO Box 30 001, 9700 RB Groningen,
the Netherlands (e-mail: mzorgdrager1985@gmail.com)
Background: Data on chronic pain after kidney donation are sparse. The aim of this study was to assess
the incidence of chronic pain after hand-assisted laparoscopic nephrectomy.
Methods: Living kidney donors who donated between 2011 and 2017 at the University Medical Centre
Groningen were included. All patients underwent hand-assisted laparoscopic donor nephrectomy. Post-
donation pain and movement disabilities were assessed using the Carolinas Comfort Scale (CCS) and a
visual analogue scale (VAS). The prevalence, severity of pain and the need for analgesics were reported.
Results: Some 333 living kidney donors with a mean age of 56 years were included. At a median of 19
(i.q.r. 10–33) months after donation, 82 donors (24⋅6 per cent) had a CCS score above 0, of which 58 (71
per cent) had a CCS score of at least 2 and 57 (70 per cent) reported movement limitations. Some 110
donors (33⋅0 per cent) had a VAS score of more than 0. Complaints mainly occurred during bending over
(12⋅3 per cent) and exercising (12⋅4 per cent). Thirty-two donors (9⋅7 per cent) required analgesics during
follow-up between donation and the time of measurement, and six of 82 (7 per cent) reported chronic
inguinal pain. In multivariable analysis, donor age (odds ratio (OR) 0⋅97, 95 per cent c.i. 0⋅95 to 0⋅99;
P= 0⋅020) and length of hospital stay (OR 1⋅21, 1⋅01 to 1⋅51; P=0⋅041) were independently associated
with chronic pain.
Conclusion: One-quarter of donors experienced chronic postdonation pain or discomfort, most of which
was bothersome. Younger donors and those with a longer postoperative hospital stay hadmore symptoms.
Paper accepted 3 January 2019
Published online 27 March 2019 in Wiley Online Library (www.bjs.co.uk). DOI: 10.1002/bjs.11127
Introduction
Transplantation with a kidney from a living donor is
the best treatment for patients with end-stage renal disease,
and leads to a better survival rate and quality of life than
transplantation with a kidney from a deceased donor1,2.
Previous studies3,4 have shown that hand-assisted laparo-
scopic (HAL) donor nephrectomy is a safe procedure with
good outcomes in terms of quality of life and quick recov-
ery. Outcomes after laparoscopic nephrectomy are super-
ior to those of open procurement in terms of blood loss,
length of hospital stay and postoperative pain5. However,
a number of donor patients suffer from chronic pain and
this poses an important barrier to living kidney donor
programmes6–9. Generally, kidney donation leads to an
increase in perceived quality of life by living kidney donors,
but chronic postoperative pain can, importantly, impair
quality of life in these otherwise healthy people10,11.
Studies12,13 investigating pain after donation have
focused mainly on short-term postoperative pain. The
aim of this study was to assess the incidence, location
and precipitating causes of chronic pain lasting at least
3months after HAL donor nephrectomy.
Methods
Patients who underwent a HAL donor nephrectomy at the
University Medical Centre Groningen were asked to com-
plete questionnaires regarding chronic pain. In accordance
with donor selection criteria, potential donors with a
history of diabetes, kidney disease or cardiovascular events
were excluded from the donation programme. Those
with hypertension were included if BP was controlled
adequately with a maximum of two antihypertensive drugs.
Exclusion criteria for the present study were: age less than
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18 years; inability to fill out the questionnaire (for example
owing to foreign language); and no longer alive at time
of inquiry. Informed consent was obtained from all parti-
cipants. The study was approved by the institutional
ethical review board (METc 2014/077). All procedures
were conducted in accordance with the Declarations
of Helsinki and Istanbul.
Donor nephrectomy procedure
All patients underwent hand-assisted laparoscopic donor
nephrectomy, either transperitoneal (HAL) or retroperi-
toneal (hand-assisted retroperitoneal nephrectomy,
HARN)14. The operation was converted to an open
procedure where necessary. The wound area was infil-
trated before surgery with 10ml 0⋅25 per cent bupivacaine
in all patients. A suprapubic transverse incision was made
for access of the Gelport® (Applied Medical, Rancho
Santa Margarita, California, USA) in both surgical pro-
cedures. All trocars (Applied Medical) were positioned
in view of the camera. One 10-mm trocar was placed in
the iliac fossa (left or right depending on the kidney to
be donated), one 10-mm periumbilical trocar for the 30∘
video port, and one 5-mm subcostal/epigastric trocar (left
or right depending on the kidney to be donated). The
kidney was dissected from surrounding tissues, and the
ureter and hilar vessels identified. The ureter and artery
were clipped (Ligaclip®; Ethicon, Johnson & Johnson,
Somerville, New Jersey, USA) and cut, and the vein was
stapled and cut (Endo GIA™ 30–2⋅5; Medtronic Covi-
dien, Minneapolis, Minnesota, USA). After removal of
the kidney via a suprapubic incision, the suprapubic fascia
was closed using a running absorbable suture. The 12-mm
trocar port sites were closed at the fascia level by means of
interrupted absorbable sutures.
Before surgery all patients were given 1000mg paraceta-
mol. Intraoperative analgesia was managed with remifen-
tanil or sufentanil using manually controlled infusion or
a target-controlled infusion system15,16. Patients received
0⋅1mg/kg piritramide/morphine 30–45min before the
end of surgery. Postoperative pain management consisted
of 1000mg paracetamol four times daily and piritramide or
morphine using a patient-controlled analgesia (PCA) tech-
nique. Non-steroidal anti-inflammatory drugs were not
used. The use of PCA on the ward was managed by the
acute pain service of the Department of Anaesthesia.
Clinical data collection
Data collected were: age; sex; BMI; glomerular filtra-
tion ratemeasured before donation using [125I]iothalamate;
surgical complications according to the Clavien–Dindo
classification17; type of donor (related, unrelated or altru-
istic); type of nephrectomy (HAL or HARN); site of
nephrectomy; duration of surgery; conversion (to open
surgery, or fromHARN toHAL); blood loss; need for rein-
tervention; and length of hospital stay (LOS). Data regard-
ing pain medication at hospital discharge were obtained
from patient medical records.
Questionnaire
The questionnaire consisted of the modified Caroli-
nas Comfort Scale (CCS) (Appendix S1, supporting
information)18,19, a visual analogue scale (VAS) with scores
ranging from 0 to 100 on a 100-mm scale20, and ques-
tions regarding the medical history and use of analgesics.
The CCS was originally validated for pain assessment
after inguinal hernia repair with use of a mesh, and was
modified in a previous study on chronic pain in kidney
recipients12. The questionnaires were sent by mail and all
those who did not reply were contacted by telephone after
4weeks. General questions were added to the enquiry to
allow assessment of potential confounding factors.
The CCS comprises eight subcategories in which
patients could indicate to what extent they experienced
pain and movement impairment on a scale from 0 (no
complaints) to 5 (disabling complaints). The subcategories
were: lying down, bending over, sitting up, activities of
daily living, coughing, walking, walking up stairs and
exercise. The patients were asked to indicate the sever-
ity of ongoing complaints at the time of filling in the
questionnaire, under the condition that these complaints
lasted at least 3months from nephrectomy to the date
of enquiry. Chronic pain was defined by complaints or
pain in the inguinal region or flank at the time of survey,
which was assessed at least 3months after surgery. Patients
with a CCS score above 0 were scored as positive for pain
(referred to as ‘patients with complaints’ in the CCS).
Patients with a CCS of at least 2 in one of the subcat-
egories were considered to have ‘significant and bother-
some complaints’, according to the CCS classification and
this was considered clinically significant.
In a subgroup of donors who also participated
in the TransplantLines study (ClinicalTrials.gov
NCT03272841), additional data regarding pain were
collected along with the CCS scores at clinical follow-up
visits after nephrectomy. These additional data consisted
of a detailed pain history, taken by a trained researcher, and
involved questions about the type of pain, intensity of pain
measured on a numerical rating scale (NRS)20,21, location,
referred pain, signs of sympathetic nerve activation, and
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2019; 106: 711–719
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Table 1 Donor characteristics
All donors (n= 333) Donors with no pain (n=251) Donors with pain (n= 82) P§
Age (years)* 56(11) 57(11) 53(11) 0⋅011¶
Sex ratio (M :F) 162 : 171 121 : 130 41 : 41 0⋅800
Height (cm)* 175(9) 175(9) 175(10) 0⋅692¶
Weight (kg)* 801(13) 81(12) 82(14) 0⋅450¶
BMI (kg/m2)* 26⋅4(3⋅3) 26⋅4(3⋅2) 26⋅6(3⋅5) 0⋅616¶
BP (mmHg)*
Systolic 127(12) 128(12) 125(11) 0⋅132¶
Diastolic 76(9) 76(9) 76(8) 0⋅974¶
GFR (ml/min)* 111(22⋅2) 110(20⋅8) 114(26⋅2) 0⋅199¶
Type of donor 0⋅084#
Living related 139 (41⋅7) 98 (39⋅0) 41 (50)
Living unrelated 166 (49⋅8) 128 (51⋅0) 38 (46)
Altruistic 28 (8⋅4) 25 (10⋅0) 3 (4)
Side of donor nephrectomy 0⋅460
Right 80 (24⋅0) 63 (25⋅1) 17 (21)
Left 253 (76⋅0) 188 (74⋅9) 65 (79)
Intended surgical technique 0⋅426
HAL 314 (94⋅3) 238 (94⋅8) 76 (93)
HARN 19 (5⋅7) 13 (5⋅2) 6 (7)
Blood loss (ml)† 0 (0–100) 0 (0–100) 0 (0–100) 0⋅674**
Duration of surgery (min)* 187(42) 186(42) 187(43) 0⋅880¶
Length of hospital stay (days)* 4⋅6(1⋅2) 4⋅5(1⋅1) 4⋅8(1⋅4) 0⋅033¶
Grade III–IV complications< 30 days‡ 8 (2⋅4) 6 (2⋅4) 2 (2) 1⋅000
Conversion rate 0⋅338#
No conversion, primary HAL 313 (94⋅0) 237 (94⋅4) 76 (93)
No conversion, primary HARN 11 (3⋅3) 9 (3⋅6) 2 (2)
Conversion of HARN to HAL 8 (2⋅4) 4 (1⋅6) 4 (5)
Conversion of HAL to open 1 (0⋅3) 1 (0⋅4) 0 (0)
Need for reoperation 2 (0⋅6) 2 (0⋅8) 0 (0) 1⋅000
Follow-up (months)† 19 (10–33) 20 (12–33) 16 (8–32) 0⋅080**
Values in parentheses are percentages unless indicated otherwise; values are *mean(s.d.) and †median (i.q.r.). ‡Clavien–Dindo grade III–IV: any
complication that requires surgical, endoscopic or radiological intervention. GFR, glomerular filtration rate; HAL, hand-assisted laparoscopy; HARN,
hand-assisted retroperitoneal nephrectomy. §Fisher’s exact test, except ¶Student’s t test, #χ2 test and **Mann–Whitney U test.
the influence of perceived pain on sleep and activities of
daily living.
Statistical analysis
Categorical variables are presented as numbers with per-
centages, and were analysed using χ2 test or Fisher’s exact
test. Continuous variables with a normal distribution are
presented as mean(s.d.) and those with a skewed distribu-
tion as median (i.q.r.), with analysis by means of Student t
test and Mann–Whitney U test respectively.
Univariable and multivariable analyses of factors associ-
ated with a higher CCS score and sensitivity analyses were
performed using logistic regression. Variables included in
the analysis were: sex, age, BMI, systolic BP, glomeru-
lar filtration rate, side of nephrectomy, type of donor
procurement (altruistic or related), blood loss, length of
hospital stay and complications. Characteristics that were
univariably associated with CCS score, or had a univari-
able P value below 0⋅200, were added to the multivari-
able model.Multiple imputation using the fully conditional
specification method was undertaken to correct for miss-
ing data, as described previously22. Two-tailed P values
were used throughout and significance was set at P< 0⋅050.
The statistical analyses were done using SPSS® version 23
(IBM, Armonk, New York, USA).
Results
Consecutive patients who underwent a HAL donor
nephrectomy between January 2011 and December 2016
were asked to complete questionnaires regarding chronic
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2019; 106: 711–719
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pain. Some 419 donors were approached at a median of 19
(i.q.r. 10–33) months after nephrectomy. A total of 333
donors completed the study questionnaires (response
rate 79⋅5 per cent), and formed the basis for this analy-
sis. Mean(s.d.) age at time of donation was 56(11) years
and 48⋅6 per cent of the donors were men. Mean BMI
at donor screening was 26⋅4(3⋅3) kg/m2 (Table 1).
Carolinas Comfort Scale and visual analogue scale
scores
Eighty-two donors (24⋅6 per cent) reported a CCS score
above 0, indicating the presence of pain symptoms at the
time of completing the surveys. Fifty-eight patients (17⋅4
per cent) experienced bothersome complaints in at least
one of the subcategories (CCS score at least 2). Themedian
CCS score for all 333 donors was 6 (4–12). Patients with a
CCS score of 2 or more had a median VAS score of 18
(3–33), whereas among those with a CCS score below 2
it was 1 (0–0). Pain was most often reported while bending
over (12⋅3 per cent) and during exercise (12⋅4 per cent)
(Table 2, Fig. 1). Fifty-seven donors (17⋅1 per cent) reported
movement limitations in the questionnaire. These also
occurred most frequently during bending over (10⋅0 per
cent) and exercising (10⋅9 per cent). Total scores for each
individual are shown in Fig. 2.
A total of 110 donors (33⋅0 per cent) reported a VAS
score of more than 0, with a median of 4(1–16). Donors
experiencing pain were younger (mean 53(11) versus 57(11)
years; P= 0⋅011) and had a longer hospital stay (mean
4⋅8(1⋅4) versus 4⋅5(1⋅1) days; P= 0⋅033), but otherwise did
not differ significantly from those without pain symptoms
(Table 1). The abdominal region (32 per cent), the site of
nephrectomy (12 per cent) and the inguinal region (7 per
cent) were the most frequently reported pain locations.
Most patients (94⋅3 per cent) underwent transperitoneal
donor procurement instead of a retroperitoneal approach.
One patient required conversion to open surgery.
Determinants of chronic pain
In univariable logistic regression analysis, age was a sig-
nificant determinant of pain, with younger donors more
frequently experiencing pain (OR per year 0⋅97, 95 per
cent c.i. 0⋅95 to 0⋅99; P= 0⋅012) (Table S1, supporting infor-
mation). A longer hospital stay was also associated with a
higher risk of developing chronic pain during follow-up
(OR 1⋅24, 1⋅01 to 1⋅52; P= 0⋅036+). Altruistic donors
showed a trend towards a lower incidence of pain (OR 0⋅33,
0⋅10 to 1⋅13; P= 0⋅075) and living related donors showed
a trend towards a higher incidence (OR 1⋅57, 0⋅95 to 2⋅60;
P= 0⋅078).





Complaints≥1 year after donation (n=230)
CCS>0 47 (20⋅4)
VAS>0 67 (29⋅1)
Pain (n=333) 82 (24⋅6)
Lying down 25 (7⋅5)
Bending over 41 (12⋅3)
Sitting up 25 (7⋅5)
Activities of daily living 29 (8⋅7)
Coughing or deep breathing 21 of 332 (6⋅3)
Walking 31 (9⋅3)
Walking up stairs 30 (9⋅0)
Exercising 40 of 322 (12⋅4)
Movement limitations (n= 333) 57 (17⋅1)
Lying down n.a.
Bending over 33 of 331 (10⋅0)
Sitting up 22 of 331 (6⋅6)
Activities of daily living 24 of 330 (7⋅3)
Coughing or deep breathing 11 of 331 (3⋅3)
Walking 20 of 331 (6⋅0)
Walking up stairs 25 of 331 (7⋅6)
Exercising 35 of 320 (10⋅9)
Pain≥1 year after donation (n=230) 47 (20⋅4)
Lying down 14 (6⋅1)
Bending over 20 (8⋅7)
Sitting up 16 (7⋅0)
Activities of daily living 18 (7⋅8)
Coughing or deep breathing 14 of 229 (6⋅1)
Walking 22 (9⋅6)
Walking up stairs 19 (8⋅3)
Exercising 25 of 228 (11⋅0)
Movement limitations≥ 1 year after donation (n= 230) 34 (14⋅8)
Bending over 13 of 228 (5⋅7)
Sitting up 10 of 228 (4⋅4)
Activities of daily living 12 of 228 (5⋅3)
Coughing or deep breathing 6 of 228 (2⋅6)
Walking 14 of 228 (6⋅1)
Walking up stairs 16 of 228 (7⋅0)
Exercising 24 of 226 (10⋅6)
Analgesic use for any indication (n= 333) 32 of 330 (9⋅7)
Location of pain (n=82)
Inguinal 6 (7)
At site of wound 10 (12)
Abdomen other 26 (32)
Extra-abdominal 8 (10)
Not specified 32 (39)
Values in parentheses are percentages. TheCarolinas Comfort Scale (CCS)
measures the severity of pain and movement limitations, on a scale from 0
(no pain/movement limitations) to 5 (severe pain/movement limitations).
The visual analogue scale (VAS) measures pain on a continuous scale,
represented by a horizontal line with scores ranging from 0 (no pain) to
100 (severe pain) on a linear scale. n.a., Not applicable.
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2019; 106: 711–719
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Percentage of living donors with a Carolinas Comfort Scale score of at least 1 for each subcategory are shown. *Movement limitations. ADL, activities of
daily living.



















Scores are plotted for 82 patients who had a Carolinas Comfort Scale
(CCS) score above zero.
Secondary analysis
In univariable analysis, younger age was associated
with increased pain in the following subdomains: lying
down (OR 0⋅95, 0⋅61 to 0⋅98; P= 0⋅003), bending over
(OR 0⋅96, 0⋅93 to 0⋅99; P= 0⋅007), sitting (OR 0⋅95, 0⋅91
to 0⋅98; P= 0⋅002), activities of daily living (OR 0⋅96,
0⋅93 to 0⋅99; P= 0⋅014), coughing (OR 0⋅95, 0⋅91 to
0⋅99; P= 0⋅006) and climbing stairs (OR 0⋅96, 0⋅93 to
0⋅99; P= 0⋅014) (Table S1, supporting information). In
linear regression, donor age (β= –0⋅06, P= 0⋅293), donor
type (β= –0⋅94, P= 0⋅348) and LOS were not associated
with the donors’ VAS score (β= –0⋅05, P= 0⋅958). Opi-
oids were prescribed more frequently at discharge from
hospital after nephrectomy among donors experiencing
pain than among those without pain (Table S2, supporting
information). In multivariable analysis, donor age (OR
0⋅97, 0⋅95 to 0⋅99; P= 0⋅020) and LOS (OR 1⋅21, 1⋅01 to
1⋅51; P= 0⋅041) remained independently associated with
pain (Table 3).
Detailed analysis of pain
A more detailed analysis of the pain symptoms was per-
formed in a subgroup of 218 donors who also partici-
pated in the TransplantLines study. Some 137 (62⋅8 per
cent) of these donors had follow-up of more than 5 years
after donation. Of the 218 donors, 46 (21⋅1 per cent)
experienced pain in the lower thorax/abdominal region,
with emphasis on hypogastric (37 of 46) or umbilical (6
of 46) areas, or lower left (5 of 46) or right (5 of 46)
abdominal quadrants. Twenty-seven of 46 donors ascribed
their pain to the nephrectomy. The pain was most often
described as stabbing (37 per cent), deep/nagging (32 per
cent) or burning (12 per cent). The median intensity
of pain on a NRS ranging from 0 to 10 was 4 (i.q.r. 2–6),
and referred pain in the stomach or back was described
in 17 per cent. Eight donors (20 per cent) described con-
tinuous pain symptoms. Three donors (8 per cent) expe-
rienced generalized symptoms such as sweating, nausea
and paleness during pain episodes, and 12 (27 per cent)
reported interference with sleep. As with the CCS score,
donors most often described the pain during bending over
(20 per cent). Most donors (54 per cent) experiencing pain
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2019; 106: 711–719
on behalf of BJS Society Ltd.
716 M. Zorgdrager, M. van Londen, L. B. Westenberg, G. J. Nieuwenhuijs-Moeke, J. F. M. Lange, M. H. de Borst et al.
Table 3 Multivariable logistic regression analysis of variables associated with different subcategories of the Carolinas Comfort Scale
CCS domain Odds ratio for CCS score> 0
Age Systolic BP Altruistic donor Related donor LOS
Total 0⋅97 (0⋅95, 0⋅99)* 0⋅99 (0⋅98, 1⋅02) 0⋅43 (0⋅11, 1⋅63) 1⋅44 (0⋅84, 2⋅44) 1⋅21 (1⋅01, 1⋅51)*
Lying 0⋅95 (0⋅91, 0⋅98)† 0⋅99 (0⋅97, 1⋅02) 0⋅49 (0⋅03, 4⋅29) 0⋅67 (0⋅28, 1⋅62) 1⋅20 (0⋅88, 1⋅64)
Bending 0⋅96 (0⋅93, 0⋅99)† 0⋅99 (0⋅97, 1⋅01) 0⋅70 (0⋅14, 3⋅47) 1⋅28 (0⋅64, 2⋅58) 1⋅21 (0⋅93, 1⋅56)
Sitting 0⋅95 (0⋅91, 0⋅98)† 0⋅98 (0⋅94, 1⋅02) 0⋅49 (0⋅05, 4⋅96) 0⋅77 (0⋅32, 1⋅87) 1⋅16 (0⋅84, 1⋅60)
Activities of daily living 0⋅96 (0⋅93, 0⋅99)* 0⋅99 (0⋅96, 1⋅01) 1⋅09 (0⋅20, 5⋅89) 1⋅27 (0⋅56, 2⋅86) 1⋅18 (0⋅88, 1⋅59)
Coughing 0⋅95 (0⋅91, 0⋅99)* 0⋅97 (0⋅93, 1⋅00) 0⋅79 (0⋅70, 9⋅93) 2⋅01 (0⋅76, 5⋅30) 1⋅28 (0⋅91, 1⋅80)
Walking 0⋅98 (0⋅94, 1⋅01) 1⋅00 (0⋅97, 1⋅02) 0⋅37 (0⋅05, 3⋅11) 1⋅06 (0⋅49, 2⋅27) 1⋅22 (0⋅92, 1⋅61)
Walking up stairs 0⋅96 (0⋅93, 0⋅99)* 1⋅00 (0⋅97, 1⋅02) 0⋅50 (0⋅06, 4⋅02) 1⋅31 (0⋅60, 2⋅87) 1⋅19 (0⋅89, 1⋅59)
Exercise 0⋅98 (0⋅95, 1⋅01) 0⋅99 (0⋅97, 1⋅01) 0⋅58 (0⋅14, 2⋅35) 0⋅86 (0⋅45, 1⋅64) 1⋅26 (0⋅99, 1⋅59)
Bothersome 0⋅97 (0⋅95, 0⋅99)* 0⋅99 (0⋅98, 1⋅02) 0⋅45 (0⋅12, 1⋅70) 1⋅29 (0⋅75, 2⋅21) 1⋅25 (1⋅02, 1⋅54)*
Values in parentheses are 95 per cent confidence intervals. CCS, Carolinas Comfort Scale; LOS, length of hospital stay. *P< 0⋅050, †P< 0⋅010.
reported no limitations in daily activities, but six (13 per
cent) experienced medium impairment and three (7 per
cent) severe impairment in their daily life.
Discussion
In this study, 24⋅6 per cent of donors experienced
chronic pain or discomfort after HAL donor nephrec-
tomy, of whom 71 per cent had bothersome complaints
(CCS score at least 2). Complaints occurred most often
during bending over and exercising, and required analgesia
in a minority of patients. These data can be used to help
raise awareness and develop individualized interventions
for pain reduction in living kidney donors that focus
on specific activities provoking these symptoms.
The incidence of chronic pain was highest in younger
patients. Previous studies reported similar results after
inguinal hernia repair23,24 and living liver donation25.
There is no clear explanation why younger patients, in
a relatively healthy population, are prone to experience
more pain, although the elderly appear to have a higher
threshold for low-intensity pain26. The complaints dur-
ing bending over are probably explained by the fact that
younger patients have a more active lifestyle. However,
differences in immune response can also contribute to
increased nociceptor activation which then can lead
to hyperalgesic priming and/or wind-up, and eventually
to central sensitization through long-term potentiation in
the central nervous system27.
Altruistic donors may be at lower risk of developing
chronic pain, although the results were not statistically
significant. It has been suggested that a specific neurocog-
nitive pathway is activated in altruistic donors28, which
may involve enhanced volume and function of the amyg-
dala, thereby dampening the biological response to pain.
Another possibility is that, because altruistic donors in the
Netherlands donate anonymously, a poor graft or recipient
outcome does not affect the donor psychologically4,11.
The hospital stay was longer in patients reporting chronic
pain. Because no difference in complication rate was found,
it might be possible that donors experiencing chronic pain
had a longer hospital stay because of a higher pain inten-
sity directly after surgery29,30. Owing to the retrospective
nature of this study, reliable estimation or collection of pain
data during the hospital admission was not possible. How-
ever, opiates were prescribed more frequently at hospital
discharge in donors with chronic pain.
Although the incidence of inguinal pain was relatively
low, the CCS scores were comparable with VAS scores,
which are frequently used in studies assessing chronic pain
after donor nephrectomy31–34.
There was no difference in chronic pain after retroperi-
toneal nephrectomy compared with transperitoneal dissec-
tion. However, the conversion rate from retroperitoneal
to transperitoneal nephrectomy was rather high (8 of 19),
which could have biased these results. No difference in
incidence of chronic pain between donors with and without
the need for conversion was demonstrated.
The results of this study may be used for the coun-
selling of future living kidney donors and their recipi-
ents. Although kidney donation generally tends to increase
donor quality of life10,11, the incidence of pain may have a
reducing effect. Even though HAL nephrectomy greatly
reduces the incidence of pain compared with an open
procedure31–33, the present findings emphasize that pain is
still an important problem affecting one-quarter of donors.
Although chronic painmay not be entirely unexpected after
major surgery, an important difference in the case of living
donors should be pointed out. Living kidney donors differ
from the normal surgical population because they undergo
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2019; 106: 711–719
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surgery voluntarily for the benefit of others, greatly affect-
ing the way they should be informed about expectations
regarding the postoperative course. In this respect, there
are important parallels with living liver donors in whom
comparable rates of chronic pain have been reported (27
per cent)25. The well-being of donors does not only reflect
their own quality of life, but has extensive psychosocial
effects on the recipient and other family relatives in terms
of reciprocity, anxiety and feelings of guilt25,35,36. This
underlines that in these specific populations every measure
should be taken to prevent chronic pain, but at least provide
enough information to come to a well considered decision.
There is a strong relationship between acute postop-
erative pain and development of chronic pain, and this
transition is likely to be caused by sensitization to pain
owing to a complex process of psychosocial and biolog-
ical factors37–40. Various interventions to prevent acute
pain after laparoscopic donor nephrectomy have been
described, but their effect on chronic pain has yet to be
clarified fully. Perioperative administration of an α2 agon-
ist (such as clonidine), lidocaine infusion, pregabalin or
ketamine have all been described as effective methods for
reducing acute postoperative pain and the need for opioid
medication28,41,42. Effective intraoperative interventions
are subfascial administration of bupivacaine, transversus
abdominis plane block, low-pressure pneumoperitoneum
and deep neuromuscular blockade43,44. Future studies are
needed to determine which approach is most appropriate
and effective in living kidney donors.
This study has a few limitations that need to be addressed.
The CCS score was primarily validated in studies report-
ing chronic pain after inguinal herniorrhaphy19 and donor
nephrectomy is performed in different anatomical planes.
For example, the peritoneal cavity is opened during HAL
nephrectomy, which could lead to a different aetiology of
pain, rather than chronic pain induced by inguinal nerve
injury, even though the same inguinal nerves are encoun-
tered at a more proximal location during donor nephrec-
tomy. This is further underlined by a subanalysis in which
the location of pain was evaluated in 46 patients, only three
of whom reported specific inguinal pain. Along with peri-
toneal visceral pain, more localized pain in the abdomen
or flank in donors could be explained by the dissection of
perforating nerves around the kidney during procurement.
These nerves are innervated by splanchnic nerve roots that
originate in the aorticorenal ganglia located at the origin of
the renal artery. This could suggest that local anaesthetic
infiltration or spraying at this level may be beneficial in
reducing the incidence or severity of postoperative pain.
Use of the CCS was preferred in this study because
it generated detailed information about complaints and
pain during activities of daily living. Because the CCS
subcategories do not focus fully on inguinal pain, it appears
applicable to other surgical populations. Kidney donors
and patients after hernia repair are similar populations,
comprising healthy individuals with a very low burden
of co-morbidity. The VAS method and Short Form 36
(SF-36) are used most in these populations, but either have
low specificity or are too extensive. A previous study45
compared the CCS with the SF-36 quality-of-life survey
and showed that 75 per cent of patients preferred the CCS
over the SF-36, mostly because it was easier to understand.
Future studies are needed to validate this short but effective
method, in which the questionnaire should be completed
before and after operation to enable an analysis relative to
baseline.
In this study, a CCS score of at least 2 was considered
clinically significant. This threshold is debatable because
no previous study has assessed chronic pain in living kid-
ney donors using the CCS survey. Furthermore, there is
significant heterogeneity among RCTs in use of definitions
for various degrees of pain46. This is partly because pain is a
highly subjective experience.When comparing two groups,
a difference of 10–30mm on a VAS scale is generally con-
sidered significant46. Patients in the present cohort with a
CCS score of 2 or more suffered from bothersome pain
and had a median VAS score of 18 (i.q.r. 3–33), in con-
trast to a VAS score of 1 (0–0) among those with a CCS
score below 2. However, owing to the retrospective nature
of this study, no comparisons could be made with preoper-
ative CCS scores.
Another limitation is the retrospective design of this
study and relatively limited follow-up (maximum 6 years).
One previous study47 reported an increased incidence of
pain 10 years after donation compared to the general pop-
ulation. However the other domains concerning quality of
life between groups were comparable. There were some
missing data in the present study as 7⋅0 per cent of patients
did not fill in the questionnaire completely. Multiple impu-
tation was used to account for the missing data22. Because
pain and movement disability are highly inter-related, the
bias from the missing answers was probably limited. In
addition, bias was further reduced by using a binary out-
come (pain or no pain) in the analyses. Data on opiate use
at discharge after nephrectomy were collected, which may
have been subject to under-reporting in the patient files.
Finally, the questionnaire was not completed at a set time
after surgery, which could also have led to bias. However,
no relationship between the duration of follow-up and inci-
dence of chronic pain was found, suggesting that this effect
was negligible.
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2019; 106: 711–719
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